lnterference of hepatotoxicity with endocrine activity in fish
lisa.baumann@uni-heidelberg.de SETAC Rome, May 2018
lnterference of hepatotoxicity with endocrine activity in fish - - PowerPoint PPT Presentation
SETAC Rome, May 2018 lnterference of hepatotoxicity with endocrine activity in fish lisa.baumann@uni-heidelberg.de Research question: He Hepatocyte Hepatotoxicant ? VTG synthesis Oo Oocyte Model hepatotoxicants Paracetamol:
lisa.baumann@uni-heidelberg.de SETAC Rome, May 2018
He Hepatocyte Oo Oocyte
VTG synthesis
Hepatotoxicant
Paracetamol: (Acetaminophen), analgesic and antipyretic drug, which is bio-activated by cytochrome P450 enzymes, leading to the production of the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) à causes oxidative stress, thiol
Isoniazid: Antibiotic drug against tuberculosis, metabolized by hepatic N-acetyltransferase and cytochrome P450 2E1 to form reactive hepatotoxic metabolites that damage hepatocytes Aspirin: (Acetylsalicylic acid), non-steroidal anti-inflammatory and antipyretic drug, activated by cytochrome P450 isoforms CYP2E1 and CYP4A1 in the liver; might inhibit mitochondrial function and cause oxidative stress
—> Impaired VTG synthesis in the liver?
Samples:
OECD TG 230 „21-day fish assay“: 10 adult females + 10 adult males per tank 3 replicates for each exposure group 21 days flow-through exposure
Zebrafish (Danio rerio)
Paracetamol (mg/L) Isoniazid (mg/L) Aspirin (mg/L) Control Control Control 1 5 10 10 50 50 100 100 75 100
n = 240 n = 240 n = 300
Paracetamol (mg/L) Isoniazid (mg/L) Aspirin (mg/L) nominal ∅ measured (n=8x3) nominal ∅ measured (n=8x3) nominal ∅ measured (n=8x3) 1 1. 1.5 5 4. 4.2 10 8. 8.0 10 13. 13.9 50 47. 47.1 50 32. 32.9 100 129.7 100 85.4 75 50. 50.4 100 65. 65.9
stopped continued at 75 mg/L
Paracetamol (mg/L) NAPQI (ng/L) nominal ∅ measured (n=8x3) ∅ measured (n=8x3) 1 1.5 0. 0.8 10 13.9 2. 2.4 100 129.7 6. 6.8
Ad Additional
effect ects in in as aspi pirin-ex expos posed ed fi fish:
Bile duct duct hy hyper perpl plas asia
Hyal alini nized ed hepat hepatocy
es
Decreas eased ed va vacuolation n n = = 30 30 per per ex expos posur ure gr group
= biomarker for hepatotoxicity (liver fibrosis) in humans
C
t r
5 m g / L 5 m g / L 7 5 m g / L 0.0 0.5 1.0 1.5 2.0 2.5
Isoniazid Hyaluronic acid / protein (ug/mg) *** Aspirin
Co 5 mg/L 50 mg/L 75 mg/L Control 10 mg/L 50 mg/L 75 mg/L 100 mg/L 1 2 3
Aspirin Hyaluronic acid / protein (ug/mg)
n n = = 60 60 per per ex expos posur ure gr group
Par Paracet acetam amol
Is Isoniazid As Aspirin fe females ma males fe females ma males fe females ma males fa fabp10 up
up
apoa
cy cyp3a65 p3a65 up
down
cy cyp2k p2k19 19 up down down down
up up/d /down = = si significant change change vs vs cont control
, p-va value < < 0. 0.05 05 n = = 15 15 per er ex expos posur ure gr group
and se sex
n = 15 per r ex expos
ure gr group and and se sex up up/d /down = = si significant chang change vs vs cont control
, p-va value < < 0.05 n = 30 per r ex expos
ure gr group and and se sex
mRNA expression levels in the liver es esr1 vt vtg1 vt vtg2
Females Males Females Males Females Males Pa Paracetamo mol down
iazid id down up down
irin in
up
Vitellogenin protein levels (head/tail homogenate)
Females Males Paracetamol slightly up
Paracetamol Isoniazid Aspirin
He Hepatocyte Oo Oocyte
VTG synthesis Hepatotoxicant
Project team: Thomas Braunbeck (University of Heidelberg) Henrik Holbech (University of Southern Denmark, Odense) Helmut Segner (University of Bern) Lennart Weltje (BASF SE, Limburgerhof) Research liaison team: Bruno Hubesch (Cefic) Grace Panter (Syngenta) Neil Wang (Arkema) Arnd Weyers (Bayer) James Wheeler (Dow AgroSciences) Lucy Wilmot (ECETOC) Co-workers: TECOmedical Annette Duus (Odense) Bente Holbech (Odense) Angela Moissl (Heidelberg) Olga Lityagina (Heidelberg) Heike Schmidt-Posthaus (Bern) Matthias Schuhmacher (Heidelberg)